[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  BiopharmaWatch [@Biopharma_Watch](/creator/twitter/Biopharma_Watch) on x XXX followers Created: 2025-07-23 15:45:02 UTC Top Market Movers: Positive News Full Access: $ABVX [65.61$] [556.10%] [July 23, 2025] Abivax Announces Positive Phase X Results from Both ABTECT 8-Week Induction Trials Investigating Obefazimod, its First-in-Class Oral miR-124 En XXX engagements  **Related Topics** [$abvx](/topic/$abvx) [Post Link](https://x.com/Biopharma_Watch/status/1948046706513424601)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
BiopharmaWatch @Biopharma_Watch on x XXX followers
Created: 2025-07-23 15:45:02 UTC
Top Market Movers: Positive News Full Access: $ABVX [65.61$] [556.10%] [July 23, 2025] Abivax Announces Positive Phase X Results from Both ABTECT 8-Week Induction Trials Investigating Obefazimod, its First-in-Class Oral miR-124 En
XXX engagements
Related Topics $abvx
/post/tweet::1948046706513424601